Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of an Integrated Prenatal and Postnatal Treatment Model to Improve the Treatment Effect of Newborns With Critical Congenital Heart Disease

NCT06768008 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT06768008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06768008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of an Integrated Prenatal and Postnatal Treatment Model to Improve the Treatment Effect of Newborns With Critical Congenital Heart Disease
Lead sponsor
Beijing Anzhen Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2022
Completion date
December 31, 2030
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, coarctation of aorta, congenital heart disease, hypoplastic left heart syndrome (hlhs), interrupted aortic arch, pulmonary atresia, pulmonary stenosis, single ventricle, tetralogy of fallot (tof), total anomalous pulmonary venous connection, transposition of the great arteries, truncus arteriosus